Positions

Professor of Psychiatry, Neurology, and Physical Medicine & Rehabilitation

Menninger Department of Psychiatry and Behavioral Sciences
Beth K. and Stuart C. Division of Neuropsychiatry
Baylor College of Medicine
Houston, TX US
Director, Beth K. and Stuart C. Yudofsky Division of Neuropsychiatry Beth K. and Stuart C. Yudofsky Chair in Brain Injury Medicine Vice Chair for Research, Department of Physical Medicine & Rehabilitation

Senior Scientist and Medical Director for Brain Injury Research

TIRR Memorial Hermann
Houston, TX

Addresses

TIRR Memorial Hermann Research Center (Office)

1333 Moursund Street
Houston, TX 77030
United States
Phone: (713) 798-7581

Greenpark 1 (Office)

7515 Main Street
Suite 300
Houston, TX 77030
United States
Phone: (713) 798-7581

Education

Fellowship at University of Colorado School of Medicine

03/1999 - Denver, Colorado United States

Neuropsychiatry and Clinical Neuroscience Research

Fellowship at Denver Veterans Affairs Medical Center

03/1999 - Denver, Colorado United States

Neuroscience Research and Traumatic Brain Injury

Residency at University of Colorado School of Medicine

06/1996 - Denver, Colorado United States

Psychiatry

Internship at University of Colorado School of Medicine

06/1993 - Denver, Colorado United States

Community Medicine

MD from University of Michigan Medical School

05/1992 - Ann Arbor, Michigan United States

Professional Interests

• Posttraumatic neuropsychiatric disturbances.
• Traumatic brain injury

Professional Statement

Dr. Arciniegas' clinical and research activities focus on the evaluation and rehabilitation of persons with traumatic brain injuries and posttraumatic neuropsychiatric disturbances.

Dr. Arciniegas is an inpatient consultation physician at TIRR Memorial Hermann rehabilitation hospital. He does not provide outpatient services.

Websites

Selected Publications

• Jorge RE, Arciniegas DB "Mood disorders after traumatic brain injury." Psychiatr Clin North Am. 2014;37(1):13-29. Pubmed PMID: 24529421
• Arciniegas DB, Anderson CA "Donepezil-induced confusional state in a patient with autopsy-proven behavioral variant frontotemporal dementia." J Neuropsychiatry Clin Neurosci. 2013;25(3):E25-6. Pubmed PMID: 24026732
• Kozora E, Arciniegas DB, Duggan E, West S, Brown MS, Filley CM "White matter abnormalities and working memory impairment in systemic lupus erythematosus (SLE)." Cogn Behav Neurol. 2013 Jun;26(2):63-72. Pubmed PMID: 23812169
• Frey KL, Newman JK, Arciniegas DB, Anderson CA, Ramsberger G "Assessing neuropsychiatric disturbances associated with post-stroke aphasia.." J Neuropsychiatry Clin Neurosci. 2011 Sep 1;23(4):E4-5. Pubmed PMID: 22231346

Memberships

American Neuropsychiatric Association

(01/1999)

International Brain Injury Association

(01/1999)

International Neuropsychiatric Association

(01/2007)

Funding

Multicenter Evaluation of Memory Remediation after Traumatic Brain Injury with Donepezil - #H133A130047

$3,000,000.00 (10/01/2013 - 09/30/2018)

Grant funding from Department of Education, NIDRR

The MEMRI-TBI-D Study is a NIDRR-funded, five-year, four-site, randomized, parallel design, double-blind, placebo-controlled, 10-week trial that will evaluate the effect of donepezil on treatment for functionally important verbal memory problems among 160 individuals (age 18-60 years) who sustained a complicated mild, moderate, or severe non-penetrating TBI six to 36 months prior to study participation.

Texas TBI Model System of TIRR - #H133A120020

$2,237,500.00 (10/01/2012 - 09/30/2017)

Grant funding from Department of Education, NIDRR

This project will contribute to the TBI Model Systems (TBIMS) National Database, implement an extensive program of TBI information and consumer education activities, and conduct a local, randomized controlled trial of a novel psychotherapy for emotional distress in persons with TBI.

Rivastigmine Patch in Veterans with Cognitive Impairment following TBI - #CX000239 (CCTA #0001)

$2,036,000.00 (07/01/2012 - 06/30/2017)

Grant funding from Department of Veterans Affairs, Office of R&D

The goal of this project is to perform a randomized, double-blind, placebo-controlled multicenter study evaluating the safety and efficacy of rivastigmine patch as a treatment for persistent memory impairments among Veterans with traumatic brain injury, with pre- and post-treatment assessments using neuropsychological measures.